Cargando…

Plasma Clusterin and the CLU Gene rs11136000 Variant Are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients

Objective: Type 2 diabetes mellitus (T2DM) is related to an elevated risk of mild cognitive impairment (MCI). Plasma clusterin is reported associated with the early pathology of Alzheimer's disease (AD) and longitudinal brain atrophy in subjects with MCI. The rs11136000 single nucleotide polymo...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Rongrong, Han, Jing, Sun, Jie, Huang, Rong, Tian, Sai, Shen, Yanjue, Dong, Xue, Xia, Wenqing, Wang, Shaohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963458/
https://www.ncbi.nlm.nih.gov/pubmed/27516739
http://dx.doi.org/10.3389/fnagi.2016.00179
_version_ 1782444956773777408
author Cai, Rongrong
Han, Jing
Sun, Jie
Huang, Rong
Tian, Sai
Shen, Yanjue
Dong, Xue
Xia, Wenqing
Wang, Shaohua
author_facet Cai, Rongrong
Han, Jing
Sun, Jie
Huang, Rong
Tian, Sai
Shen, Yanjue
Dong, Xue
Xia, Wenqing
Wang, Shaohua
author_sort Cai, Rongrong
collection PubMed
description Objective: Type 2 diabetes mellitus (T2DM) is related to an elevated risk of mild cognitive impairment (MCI). Plasma clusterin is reported associated with the early pathology of Alzheimer's disease (AD) and longitudinal brain atrophy in subjects with MCI. The rs11136000 single nucleotide polymorphism within the clusterin (CLU) gene is also associated with the risk of AD. We aimed to investigate the associations among plasma clusterin, rs11136000 genotype and T2DM-associated MCI. Methods: A total of 231 T2DM patients, including 126 MCI and 105 cognitively healthy controls were enrolled in this study. Demographic parameters were collected and neuropsychological tests were conducted. Plasma clusterin and CLU rs11136000 genotype were examined. Results: Plasma clusterin was significantly higher in MCI patients than in control group (p = 0.007). In subjects with MCI, plasma clusterin level was negatively correlated with Montreal cognitive assessment and auditory verbal learning test_delayed recall scores (p = 0.027 and p = 0.020, respectively). After adjustment for age, educational attainment, and gender, carriers of rs11136000 TT genotype demonstrated reduced risk for MCI compared with the CC genotype carriers (OR = 0.158, χ(2) = 4.113, p = 0.043). Multivariable regression model showed that educational attainment, duration of diabetes, high-density lipoprotein cholesterol (HDL-c), and plasma clusterin levels are associated with MCI in T2DM patients. Conclusions: Plasma clusterin was associated with MCI and may reflect a protective response in T2DM patients. TT genotype exhibited a reduced risk of MCI compared to CC genotype. Further investigations should be conducted to determine the role of clusterin in cognitive decline. Trial registration Advanced Glycation End Products Induced Cognitive Impairment in Diabetes: BDNF Signal Meditated Hippocampal Neurogenesis ChiCTR-OCC-15006060; http://www.chictr.org.cn/showproj.aspx?proj=10536
format Online
Article
Text
id pubmed-4963458
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-49634582016-08-11 Plasma Clusterin and the CLU Gene rs11136000 Variant Are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients Cai, Rongrong Han, Jing Sun, Jie Huang, Rong Tian, Sai Shen, Yanjue Dong, Xue Xia, Wenqing Wang, Shaohua Front Aging Neurosci Neuroscience Objective: Type 2 diabetes mellitus (T2DM) is related to an elevated risk of mild cognitive impairment (MCI). Plasma clusterin is reported associated with the early pathology of Alzheimer's disease (AD) and longitudinal brain atrophy in subjects with MCI. The rs11136000 single nucleotide polymorphism within the clusterin (CLU) gene is also associated with the risk of AD. We aimed to investigate the associations among plasma clusterin, rs11136000 genotype and T2DM-associated MCI. Methods: A total of 231 T2DM patients, including 126 MCI and 105 cognitively healthy controls were enrolled in this study. Demographic parameters were collected and neuropsychological tests were conducted. Plasma clusterin and CLU rs11136000 genotype were examined. Results: Plasma clusterin was significantly higher in MCI patients than in control group (p = 0.007). In subjects with MCI, plasma clusterin level was negatively correlated with Montreal cognitive assessment and auditory verbal learning test_delayed recall scores (p = 0.027 and p = 0.020, respectively). After adjustment for age, educational attainment, and gender, carriers of rs11136000 TT genotype demonstrated reduced risk for MCI compared with the CC genotype carriers (OR = 0.158, χ(2) = 4.113, p = 0.043). Multivariable regression model showed that educational attainment, duration of diabetes, high-density lipoprotein cholesterol (HDL-c), and plasma clusterin levels are associated with MCI in T2DM patients. Conclusions: Plasma clusterin was associated with MCI and may reflect a protective response in T2DM patients. TT genotype exhibited a reduced risk of MCI compared to CC genotype. Further investigations should be conducted to determine the role of clusterin in cognitive decline. Trial registration Advanced Glycation End Products Induced Cognitive Impairment in Diabetes: BDNF Signal Meditated Hippocampal Neurogenesis ChiCTR-OCC-15006060; http://www.chictr.org.cn/showproj.aspx?proj=10536 Frontiers Media S.A. 2016-07-28 /pmc/articles/PMC4963458/ /pubmed/27516739 http://dx.doi.org/10.3389/fnagi.2016.00179 Text en Copyright © 2016 Cai, Han, Sun, Huang, Tian, Shen, Dong, Xia and Wang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Cai, Rongrong
Han, Jing
Sun, Jie
Huang, Rong
Tian, Sai
Shen, Yanjue
Dong, Xue
Xia, Wenqing
Wang, Shaohua
Plasma Clusterin and the CLU Gene rs11136000 Variant Are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients
title Plasma Clusterin and the CLU Gene rs11136000 Variant Are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients
title_full Plasma Clusterin and the CLU Gene rs11136000 Variant Are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients
title_fullStr Plasma Clusterin and the CLU Gene rs11136000 Variant Are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients
title_full_unstemmed Plasma Clusterin and the CLU Gene rs11136000 Variant Are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients
title_short Plasma Clusterin and the CLU Gene rs11136000 Variant Are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients
title_sort plasma clusterin and the clu gene rs11136000 variant are associated with mild cognitive impairment in type 2 diabetic patients
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963458/
https://www.ncbi.nlm.nih.gov/pubmed/27516739
http://dx.doi.org/10.3389/fnagi.2016.00179
work_keys_str_mv AT cairongrong plasmaclusterinandtheclugeners11136000variantareassociatedwithmildcognitiveimpairmentintype2diabeticpatients
AT hanjing plasmaclusterinandtheclugeners11136000variantareassociatedwithmildcognitiveimpairmentintype2diabeticpatients
AT sunjie plasmaclusterinandtheclugeners11136000variantareassociatedwithmildcognitiveimpairmentintype2diabeticpatients
AT huangrong plasmaclusterinandtheclugeners11136000variantareassociatedwithmildcognitiveimpairmentintype2diabeticpatients
AT tiansai plasmaclusterinandtheclugeners11136000variantareassociatedwithmildcognitiveimpairmentintype2diabeticpatients
AT shenyanjue plasmaclusterinandtheclugeners11136000variantareassociatedwithmildcognitiveimpairmentintype2diabeticpatients
AT dongxue plasmaclusterinandtheclugeners11136000variantareassociatedwithmildcognitiveimpairmentintype2diabeticpatients
AT xiawenqing plasmaclusterinandtheclugeners11136000variantareassociatedwithmildcognitiveimpairmentintype2diabeticpatients
AT wangshaohua plasmaclusterinandtheclugeners11136000variantareassociatedwithmildcognitiveimpairmentintype2diabeticpatients